Document is current
Any future updates will be listed below
-
Authors
Tsutsui, Anna https://orcid.org/0000-0001-7696-3717
Murakami, Yoshitaka
Nishiwaki, Yuji
Asakura, Keiko
Ohfuji, Satoko
Fukushima, Wakaba
Matsuoka, Katsuyoshi
Hisamatsu, Tadakazu
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (23FC1027)
- License Information
-
More Information
Article History
Received: 12 June 2025
Accepted: 26 August 2025
First Online: 2 September 2025
Declarations
:
: AT and YM received commissioned research funding from Daiichi Sankyo Company, Limited for the Department of Medical Statistics, Toho University in the past 36 months. AT also holds stock in AstraZeneca PLC. YM also served on the advisory board for Cardiopoint Japan K.K. in the past 36 months. KM received research grants and contracts from Mochida Pharmaceutical Co., Ltd., EA Pharma Co., Ltd., AbbVie GK, and Nippon Kayaku Co., Ltd. in the past 36 months. KM also received consulting fees from Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited, Janssen Pharmaceutical K.K., AbbVie GK, EA Pharma Co., Ltd., Pfizer Japan Inc., Mochida Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Gilead Sciences K.K., Celltrion Healthcare Japan K.K., Eli Lilly Japan K.K., and Bristol-Myers Squibb K.K. in the past 36 months. KM also received payments and honoraria from Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited, Janssen Pharmaceutical K.K., AbbVie GK, EA Pharma Co., Ltd., Pfizer Japan Inc., Mochida Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Zeria Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Gilead Sciences K.K., Celltrion Healthcare Japan K.K., Eli Lilly Japan K.K., and Bristol-Myers Squibb K.K. in the past 36 months. TH received research grants from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., Ltd., AbbVie GK, JIMRO Co., Ltd., Zeria Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., Mochida Pharmaceutical Co., Ltd., Boston Scientific Corporation, and Kissei Pharmaceutical Co., Ltd. in the past 36 months. TH also received consulting fees from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Pfizer Inc., Eli Lilly, Gilead Sciences, Bristol-Myers Squibb, and Abivax in the past 36 months. TH also received lecture fees from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd., JIMRO Co., Ltd., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., and Kissei Pharmaceutical Co., Ltd. in the past 36 months.
